UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹886 Cr | ₹992 Cr | ₹738 Cr | ₹640 Cr | ₹552 Cr |
What is the latest Total Current Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹886 Cr |
| Mar2025 | ₹992 Cr |
| Mar2024 | ₹738 Cr |
| Mar2023 | ₹640 Cr |
| Mar2022 | ₹552 Cr |
How is Total Current Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹886 Cr | -10.69 | |
| Mar2025 | ₹992 Cr | 34.49 | |
| Mar2024 | ₹738 Cr | 15.32 | |
| Mar2023 | ₹640 Cr | 15.84 | |
| Mar2022 | ₹552 Cr | - | |
Compare Total Current Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,918.1 Cr | 2.2% | 16.6% | 8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 2.2% |
16.6% |
8.9% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses